“Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis.” Yasuhiro Kondoh, Vincent Cottin and Kevin K. Brown. Eur Respir Rev 2017; 26: 170050.
Related content which might interest you:
“Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis.” Vincent Cottin and Toby Maher. Eur Respir Rev 2015; 24: 58–64. Source: Eur Respir Rev 2015; 24: 545 Year: 2015
“Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice.” Stephen Y. Chan and Lewis J. Rubin. Eur Respir Rev 2017; 26: 170094. Source: Eur Respir Rev, 27 (147) 175094; 10.1183/16000617.5094-2017 Year: 2018
“Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis.” Bridget F. Collins and Ganesh Raghu. Eur Respir Rev 2019; 28: 190022. Source: Eur Respir Rev, 28 (154) 195022; 10.1183/16000617.5022-2019 Year: 2019
“Cardiovascular disease and COPD: dangerous liaisons?” Klaus F. Rabe, John R. Hurst and Samy Suissa. Eur Respir Rev 2018; 27: 180057. Source: Eur Respir Rev, 27 (150) 185057; 10.1183/16000617.5057-2018 Year: 2018
“Serious bronchopulmonary involvement due to chronic lymphocytic leukaemia.” Delphine Carmier Catherine Dartigeas Julie Mankikian Cecilla Rousselot-Denis Severine Lissandre Patrice Diot, Sylvain Marchand-Adam. Eur Respir Rev 2013; 22: 416–419. Source: Eur Respir Rev 2013; 22: 589 Year: 2013
“Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.” Irene Lang, Bernhard C. Meyer, Takeshi Ogo, Hiromi Matsubara, Marcin Kurzyna, Hossein-Ardeschir Ghofrani, Eckhard Mayer and Philippe Brenot. Eur Respir Rev 2017; 26: 160119. Source: Eur Respir Rev, 26 (144) 165119; 10.1183/16000617.5119-2016 Year: 2017
“Is bronchiectasis really a disease?” Michal Shteinberg, Patrick A. Flume and James D. Chalmers. Eur Respir Rev 2020; 29: 190051. Source: Eur Respir Rev, 29 (155) 195051; 10.1183/16000617.5051-2019 Year: 2020
“Cellular mechanisms underlying steroid-resistant asthma.” Ridhima Wadhwa, Kamal Dua, Ian M. Adcock, Jay C. Horvat, Richard Y. Kim and Philip M. Hansbro. Eur Respir Rev 2019; 28: 190021. Source: Eur Respir Rev, 28 (154) 195096; 10.1183/16000617.5096-2019 Year: 2019
“Idiopathic inflammatory myopathies and the lung.” Jean-Christophe Lega, Quitterie Reynaud, Alexandre Belot, Nicole Fabien, Isabelle Durieu and Vincent Cottin. Eur Respir Rev 2015; 24: 216–238. Source: Eur Respir Rev 2015; 24: 545 Year: 2015
“Differential diagnosis of usual interstitial pneumonia: when is it truly idiopathic?” Wim A. Wuyts, Alberto Cavazza, Giulio Rossi, Francesco Bonella, Nicola Sverzellati and Paolo Spagnolo. Eur Respir Rev 2014; 23: 308–319. Source: Eur Respir Rev 2014; 23: 537 Year: 2014
“Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.” Michael Kreuter, Marlies S. Wijsenbeek, Martina Vasakova, Paolo Spagnolo, Martin Kolb, Ulrich Costabel, Derek Weycker, Klaus-Uwe Kirchgaessler and Toby M. Maher. Eur Respir J 2016; 47: 1776–1784. Source: Eur Respir J 2016; 48: 593 Year: 2016
“Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing.” Denis E. O'Donnell, Amany F. Elbehairy, Azmy Faisal, Katherine A. Webb, J. Alberto Neder and Donald A. Mahler. Eur Respir Rev 2016; 25: 333–347. Source: Eur Respir Rev 2016; 25: 513 Year: 2016
“The therapy of idiopathic pulmonary fibrosis: what is next?” Vivien Somogyi, Nazia Chaudhuri, Sebastiano Emanuele Torrisi, et al . Eur Respir Rev 2019; 28: 190021. Source: Eur Respir Rev, 28 (153) 195021; 10.1183/16000617.5021-2019 Year: 2019
“Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes.” Sabina A. Guler, Joanne M. Kwan, Janice M. Leung, Nasreen Khalil, Pearce G. Wilcox and Christopher J. Ryerson. Eur Respir J 2020; 55: 1900647. Source: Eur Respir J, 55 (3) 1950647; 10.1183/13993003.50647-2019 Year: 2020
“Triple therapy in idiopathic pulmonary fibrosis: an alarming press release.” A.U. Wells, J. Behr, U. Costabel, V. Cottin and V. Poletti. Eur Respir J 2012; 39: 805–806. Source: Eur Respir J 2012; 39: 1552 Year: 2012
“Recent advances in targeting the prostacyclin pathway in pulmonary arterial hypertension.” Irene M. Lang and Sean P. Gaine. Eur Respir Rev 2015; 24: 630–641. Source: Eur Respir Rev 2015; 25: 99 Year: 2016
“Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results”. Robert Wilson, Antonio Anzueto, Marc Miravitlles, Pierre Arvis, Jeff Alder, Daniel Haverstock, Mila Trajanovic and Sanjay Sethi. Eur Respir J 2012; 40: 17–27.}, Source: Eur Respir J 2012; 40: 800 Year: 2012
“Cladribine improves lung cysts and pulmonary function in a child with histiocytosis.” Ralph Epaud, Hubert Ducou Le Pointe, Sylvie Fasola, Sandra Ploussard, Celine Delestrain, Chiara Sileo and Jean Donadieu. Eur Respir J 2015; 45: 831–833. Source: Eur Respir J 2016; 47: 692 Year: 2016
“Characterisation of patients with interstitial pneumonia with autoimmune features.” Justin M. Oldham, Ayodeji Adegunsoye, Eleanor Valenzi, Cathryn Lee, Leah Witt, Lena Chen, Aliya N. Husain, Steven Montner, Jonathan H. Chung, Vincent Cottin, Aryeh Fischer, Imre Noth, Rekha Vij and Mary E. Strek. Eur Respir J 2016; 47: 1767–1775. Source: Eur Respir J, 49 (5) 1551565; 10.1183/13993003.51565-2015 Year: 2017
“RESPIRE: breathing new life into bronchiectasis.” Sanjay H. Chotirmall and James D. Chalmers. Eur Respir J 2018; 51: 1702444. Source: Eur Respir J, 51 (2) 1752444; 10.1183/13993003.52444-2017 Year: 2018